•Lower response rate in EFR compared to the literature•IL-1 inhibitors as a treatment of choice in CAPS•IL-1 blockade as an therapeutic alternative in FMF, TRAP andMKD. This evidence concerns the gene IL1A and cryopyrin-associated periodic syndrome.